DrugPatentWatch Database Preview
Drugs in Development Information for Dapaconazole
» See Plans and Pricing
What is the development status for investigational drug Dapaconazole?
Dapaconazole is an investigational drug.
There have been 4 clinical trials for Dapaconazole.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2017.
The most common disease conditions in clinical trials are Tinea, Tinea Pedis, and [disabled in preview]. The leading clinical trial sponsors are Biolab Sanus Farmaceutica, Galeno Desenvolvimento de Pesquisas Clínicas, and Gilberto De Nucci.
There is one US patent protecting this investigational drug and twenty-six international patents.
Summary for Dapaconazole
| US Patents | 1 |
| International Patents | 26 |
| US Patent Applications | 1 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2017-11-01) |
| Vendors | 4 |
Recent Clinical Trials for Dapaconazole
| Title | Sponsor | Phase |
|---|---|---|
| Non-inferiority Trial of Dapaconazole Versus Ketoconazole | Biolab Sanus Farmaceutica | Phase 3 |
| Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis | Biolab Sanus Farmaceutica | Phase 3 |
| Clinical Trial Comparing BL123 Versus Ketoconazole in Patients With Tinea Pedis | Biolab Sanus Farmaceutica | Phase 2 |
Clinical Trial Summary for Dapaconazole
Top disease conditions for Dapaconazole
Top clinical trial sponsors for Dapaconazole
US Patents for Dapaconazole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Dapaconazole | Start Trial | Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same | Biolab Sanus Farmaceutical Ltda. (Sao Paulo, BR) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Dapaconazole
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Dapaconazole | Argentina | 078115 | 2029-08-28 | Start Trial |
| Dapaconazole | Australia | 2010286266 | 2029-08-28 | Start Trial |
| Dapaconazole | Brazil | PI0904249 | 2029-08-28 | Start Trial |
| Dapaconazole | Canada | 2771044 | 2029-08-28 | Start Trial |
| Dapaconazole | Chile | 2012000463 | 2029-08-28 | Start Trial |
| Dapaconazole | China | 102625800 | 2029-08-28 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
